Vertex Pharmaceuticals Inc (VRTX)

Net profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Net income (ttm)	US$ in thousands	-535,600	-479,800	-489,900	4,019,400	3,619,600	3,469,700	3,364,900	3,259,700	3,322,000	3,273,200	3,194,600	2,451,100	2,342,100	2,176,190	1,991,724	2,761,994	2,711,647	2,690,691	2,080,775	1,510,932
Revenue (ttm)	US$ in thousands	10,984,000	10,582,900	10,283,600	10,120,000	9,803,200	9,596,700	9,444,700	9,144,300	8,863,500	8,628,770	8,277,080	7,873,370	7,499,400	7,066,960	6,622,470	6,355,190	6,147,530	5,935,020	5,347,582	4,763,428
Net profit margin		-4.88%	-4.53%	-4.76%	39.72%	36.92%	36.16%	35.63%	35.65%	37.48%	37.93%	38.60%	31.13%	31.23%	30.79%	30.08%	43.46%	44.11%	45.34%	38.91%	31.72%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-535,600K ÷ $10,984,000K
= -4.88%

Vertex Pharmaceuticals Inc's net profit margin has shown fluctuating trends over the period covered in the data. The company's net profit margin increased steadily from March 2020 to December 2021, reaching a peak of 44.11%. However, from March 2022 onwards, there was a slight decline in the net profit margin, with fluctuations observed in subsequent quarters. Notably, there was a significant decrease in the net profit margin in June 2024, dropping to -4.76%.

Overall, Vertex Pharmaceuticals Inc's net profit margin demonstrates a mix of positive and negative movements, indicating variability in the company's profitability performance over the years, which may warrant further investigation into the factors influencing these fluctuations.